newsfilter
← Latest News
GlobeNewswire·

Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule

NEWTOWN, Pa., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ:TRAW) ("Traws" or "Traws Pharma"), a clinical stage biopharmaceutical company developing oral small molecules for the treatment of respiratory